Top compounds associated with response to PCDHGA11


Feature Type Standardized
Nominal ANOVA
mRNA SR8278 CTRPv2 pan-cancer AAC -0.076 0.7
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.019 0.7
mRNA ETP-46464 CTRPv2 pan-cancer AAC 0.02 0.7
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.017 0.7
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.017 0.7
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.017 0.7
mRNA thalidomide CTRPv2 pan-cancer AAC -0.025 0.7
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.016 0.7
mRNA CID-5951923 CTRPv2 pan-cancer AAC 0.018 0.7
mRNA AC55649 CTRPv2 pan-cancer AAC -0.017 0.7
Download CSV